Overview
MIST market data
Price History
MIST price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.75 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.98 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.00 – $3.06 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $150.6 · P/B 4.12 · P/S 84.44.
Company news
8-K filing — Milestone Pharmaceuticals Inc. (MIST)SEC EDGAR · Jun 15, 2026, 8:05 PM
Wells Fargo Maintains Overweight on Milestone Pharmaceuticals, Lowers Price Target to $7Benzinga · May 14, 2026, 2:24 PM
Milestone Pharmaceuticals May Offer Up To $100M Common Shares Via Cantor Fitzgerald Sales AgreementBenzinga · May 13, 2026, 9:36 PM
Milestone Pharmaceuticals Files Prospectus To Offer Securities Up To $300MBenzinga · May 13, 2026, 9:34 PM
Milestone Reports Q1 Results, Highlights Initial CARDAMYST SalesBenzinga · May 13, 2026, 2:04 PM
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 13, 2026, 1:40 PM
Milestone Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS results.Benzinga · May 13, 2026, 1:26 PM
Milestone Expands CARDAMYST Push Into Europe, China And New AFib TrialBenzinga · May 13, 2026, 11:13 AM
Earnings Scheduled For May 13, 2026Benzinga · May 13, 2026, 11:11 AM
Milestone Pharmaceuticals Q1 EPS $(0.20) Misses $0.14 Estimate, Sales $238.000KBenzinga · May 13, 2026, 11:06 AM